Edwards Lifesciences Corp. (EW)
90.87
+0.37
(+0.41%)
USD |
NYSE |
Aug 25, 16:00
90.59
-0.28
(-0.31%)
After-Hours: 18:00
Edwards Lifesciences Free Cash Flow : 1.434B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.434B |
| March 31, 2026 | 1.090B |
| December 31, 2025 | 1.335B |
| September 30, 2025 | 799.60M |
| June 30, 2025 | 577.90M |
| March 31, 2025 | 623.10M |
| December 31, 2024 | 259.90M |
| September 30, 2024 | 490.10M |
| June 30, 2024 | 551.80M |
| March 31, 2024 | 238.10M |
| December 31, 2023 | 629.50M |
| September 30, 2023 | 774.90M |
| June 30, 2023 | 668.70M |
| March 31, 2023 | 985.40M |
| December 31, 2022 | 953.40M |
| September 30, 2022 | 1.040B |
| June 30, 2022 | 1.261B |
| March 31, 2022 | 1.428B |
| December 31, 2021 | 1.402B |
| September 30, 2021 | 1.409B |
| June 30, 2021 | 1.051B |
| March 31, 2021 | 716.70M |
| December 31, 2020 | 647.00M |
| September 30, 2020 | 688.40M |
| June 30, 2020 | 936.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.083B |
| December 31, 2019 | 901.00M |
| September 30, 2019 | 808.50M |
| June 30, 2019 | 704.50M |
| March 31, 2019 | 522.50M |
| December 31, 2018 | 685.10M |
| September 30, 2018 | 761.70M |
| June 30, 2018 | 772.00M |
| March 31, 2018 | 820.60M |
| December 31, 2017 | 825.20M |
| September 30, 2017 | 651.10M |
| June 30, 2017 | 541.20M |
| March 31, 2017 | 558.40M |
| December 31, 2016 | 528.10M |
| September 30, 2016 | 456.50M |
| June 30, 2016 | 475.40M |
| March 31, 2016 | 473.90M |
| December 31, 2015 | 447.00M |
| September 30, 2015 | 439.40M |
| June 30, 2015 | 257.00M |
| March 31, 2015 | 867.30M |
| December 31, 2014 | 939.40M |
| September 30, 2014 | 971.40M |
| June 30, 2014 | 1.087B |
| March 31, 2014 | 423.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Stryker Corp. | 4.702B |
| Intuitive Surgical, Inc. | 3.223B |
| Abbott Laboratories | 7.824B |
| Boston Scientific Corp. | 3.625B |
| Zimmer Biomet Holdings, Inc. | 1.079B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 651.90M |
| Cash from Investing (Quarterly) | -193.20M |
| Cash from Financing (Quarterly) | -0.30M |
| Free Cash Flow Per Share (Quarterly) | 1.013 |
| Free Cash Flow to Equity (Quarterly) | 583.50M |
| Free Cash Flow to Firm (Quarterly) | 585.00M |
| Free Cash Flow Yield | 2.71% |